Log in
Enquire now
‌

US Patent 9725461 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Patent 9725461 was granted and assigned to Curis (company) on August, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Curis (company)
Curis (company)
0
Current Assignee
Curis (company)
Curis (company)
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
97254610
Patent Inventor Names
Xiong Cai0
Changgeng Qian0
Chengjung Lai0
Haixaio Zhai0
Date of Patent
August 8, 2017
0
Patent Application Number
145393270
Date Filed
November 12, 2014
0
Patent Primary Examiner
‌
Rebecca Anderson
0
Patent abstract

The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9725461 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.